Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT06723028

Mobile Regulation of Craving Training (mROC-T) to Improve Dietary Intake in Rural Adolescent Girls

Sponsor: University of Wyoming

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to test if a regulation of craving training intervention in the form of a mobile phone app can increase fruit and vegetable intake in adolescent girls ages 14-18 years of age. The main questions it aims to answer are: 1. What is the effect of a mobile app version of the regulation of craving training intervention on healthy eating index scores over one year? 2. What is the effect of a mobile app version of the regulation of craving training intervention on body mass index, waist circumference, and blood glucose over one year? Researchers will compare the active regulation of craving training arm to a control fun food fact arm to see if the regulation of craving training improves HEI scores, BMI, and blood glucose over a year. Participants will be asked to play the regulation of craving training mobile app twice a week for a year.

Key Details

Gender

FEMALE

Age Range

15 Years - 18 Years

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2025-02-01

Completion Date

2026-02-01

Last Updated

2025-04-16

Healthy Volunteers

Yes

Conditions

Obesity and Type 2 Diabetes Diet Modification

Interventions

BEHAVIORAL

Regulation of craving training

Participants randomized into the active mROC-T intervention (mROC-T+ or mROC-Tc) will: 1. Read a brief essay about either the social justice benefits of eating healthy foods (POSITIVE, mROCT+) or critical of social justice aspects of unhealthy foods (CRITICAL, mROC-Tc). 2. Participants complete six free-response questions to ensure that they understood the essays. 3\. Participants are instructed to use the information from the essay. They are shown a cue matching the essay they read either: "Think Positive" or "Think Critically". 4\. They are shown an image of a healthy food (no added sugar and \< 2g/serving saturated fat) OR an image of an unhealthy food (contain added sugar and/or \>4.5g/serving saturated fat). 5. Finally, the participant is asked to rate how strong their craving is for the pictured food. The participant indicates their craving on a VAS from 1 (No craving at all) to 5 (Very high craving)

Inclusion Criteria: * Biologically female * Female gender * Between the ages of 15y and 18y Exclusion Criteria: * Biologically male * Self-identify as male * BMI percentile (for age and sex) \< 5th% * Diagnosis from a medical profession of any of the following conditions, syndromes, diseases that may affect growth, glucose metabolism, blood clotting, cognitive development\*: * Any form of or history of cancer * Any form of diabetes (type I, II, insipidus) * Precocious puberty * Crohn's disease * Congenital heart defect * Cystic fibrosis * Cerebral palsy * Anorexia nervosa * Bulimia nervosa * Active infection * Fever * Hemophilia * Hydrocephalus * intestinal atresia * Jeune syndrome * Klippel-Trénaunay syndrome * Legg-Calvé-Perthes * Long QT syndrome * Muenke syndrome * Myelomeningocele * Necrotizing Enterocolitis * Neutropenia * Non-alcholoic fatty liver diease * Pfeiffer Syndrome * Saethre-Chotzen syndrome * Shwachman-Diamond syndrome * Spinal muscular atrophy * Sturge-Weber syndrome * Ulcerative Colitis * von Willebrand disease * Pancreatitis * Hurler syndrome * Niemann-Pick disease * Tay-Sachs disease * Gaucher disease * Krabbe disease * Zellweger syndrome * Wilson disease * Brachial Plexus Palsy * Brain Abscess or Spinal Abscess * Coarctation of the Aorta * Aortic stenosis * Ventricular septal defect * Patent ductus arteriosus or mitral valve abnormalities * Congenital Adrenal Hyperplasia * Craniofacial Microsomia * Duchenne Muscular Dystrophy * Dyskeratosis Congenita * Galactosemia * Maple syrup urine disease * Phenylketonuria * Turner syndrome * Prader-Wili disease * History of polycystic ovary syndrome * History of thyroid disease (either hyper or hypo) * History of adrenal disease (including Cushing's syndrome, Addison's disease) * Use of medications related to metabolism/weight such as insulin, corticosteroids, growth hormone, sulfonylurea, thiazolidinediones, beta blockers, calcium channel blockers, bupropion, reboxetine, molindone, clozapine, olanzapine, topiramate, zonisamide, valproate, carbamazepine, lithium, hypolipidemic drugs, highly-active antiretroviral therapies

Locations (1)

University of Wyoming

Laramie, Wyoming, United States